Krebs Biochemicals and Industries Limited — Board Meeting, 26-06-2026: Outcome of Board Meeting
26-06-2026 | 01:17 pm
26-06-2026 | 01:17 pm
Krebs Biochemicals' board approved its merger with Ipca Laboratories. Krebs shareholders will receive 7 Ipca shares (Re 1/- each) for every 200 Krebs shares (Rs 10/- each). The move targets operational synergies and strengthens Ipca's API supply through Krebs' fermentation tech.
No comments yet. Be the first to comment!
All announcements from Krebs Biochemicals and Industries Limited
